These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27144597)

  • 1. Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense.
    Kaur P; Datta S; Shandil RK; Kumar N; Robert N; Sokhi UK; Guptha S; Narayanan S; Anbarasu A; Ramaiah S
    PLoS One; 2016; 11(5):e0154513. PubMed ID: 27144597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput cidality screen for Mycobacterium tuberculosis.
    Kaur P; Ghosh A; Krishnamurthy RV; Bhattacharjee DG; Achar V; Datta S; Narayanan S; Anbarasu A; Ramaiah S
    PLoS One; 2015; 10(2):e0117577. PubMed ID: 25693161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
    Li W; Obregón-Henao A; Wallach JB; North EJ; Lee RE; Gonzalez-Juarrero M; Schnappinger D; Jackson M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TB drug development: immunology at the table.
    Nathan C; Barry CE
    Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen.
    Jayaswal S; Kamal MA; Dua R; Gupta S; Majumdar T; Das G; Kumar D; Rao KV
    PLoS Pathog; 2010 Apr; 6(4):e1000839. PubMed ID: 20419122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.
    Weinstein EA; Yano T; Li LS; Avarbock D; Avarbock A; Helm D; McColm AA; Duncan K; Lonsdale JT; Rubin H
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4548-53. PubMed ID: 15767566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis.
    Defelipe LA; Do Porto DF; Pereira Ramos PI; Nicolás MF; Sosa E; Radusky L; Lanzarotti E; Turjanski AG; Marti MA
    Tuberculosis (Edinb); 2016 Mar; 97():181-92. PubMed ID: 26791267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting tuberculosis by drugs targeting nonreplicating
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
    de Knegt GJ; Dickinson L; Pertinez H; Evangelopoulos D; McHugh TD; Bakker-Woudenberg IAJM; Davies GR; de Steenwinkel JEM
    Tuberculosis (Edinb); 2017 Jul; 105():113-118. PubMed ID: 28610782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems-level modeling of mycobacterial metabolism for the identification of new (multi-)drug targets.
    Rienksma RA; Suarez-Diez M; Spina L; Schaap PJ; Martins dos Santos VA
    Semin Immunol; 2014 Dec; 26(6):610-22. PubMed ID: 25453232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.
    Rifat D; Campodónico VL; Tao J; Miller JA; Alp A; Yao Y; Karakousis PC
    Future Microbiol; 2017 Jul; 12(9):753-765. PubMed ID: 28343421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine-Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis.
    Olmo ED; Molina-Salinas GM; Bini EI; González-Hernández S; Bustos LA; Escarcena R; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; González-Ramírez D; Fernández SS; San Feliciano A; Hernández-Pando R
    Arch Med Res; 2016 May; 47(4):262-70. PubMed ID: 27664485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice.
    Senaratne RH; De Silva AD; Williams SJ; Mougous JD; Reader JR; Zhang T; Chan S; Sidders B; Lee DH; Chan J; Bertozzi CR; Riley LW
    Mol Microbiol; 2006 Mar; 59(6):1744-53. PubMed ID: 16553880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.